Investigation Choice for Acute Chest Pain with ECG Changes

The patient presents with symptoms highly suggestive of an acute cardiac event, specifically an acute myocardial infarction (MI). Key indicators include acute chest pain, breathlessness, palpitations, and importantly, ST elevations in the anterior chest leads on the ECG. This ECG finding points towards a potential ST-elevation myocardial infarction (STEMI).

Rationale for Next Investigation

In the context of suspected acute MI, the immediate priority is to confirm myocardial injury. Evaluating the options:

• Cardiac marker troponin T/I: Cardiac troponins (like Troponin T or Troponin I) are proteins released into the bloodstream when heart muscle is damaged. They are highly sensitive and specific indicators of myocardial necrosis. Elevated levels confirm MI and are crucial for diagnosis and management decisions, especially in acute settings. This is the most direct and immediate test to confirm heart muscle damage suggested by the symptoms and ECG.
• Echocardiography: While useful for assessing heart function, wall motion abnormalities, and complications, it is typically performed after initial diagnosis and stabilization, or if the diagnosis remains unclear after initial biomarker tests.
• TMT (Treadmill Test): This is a stress test used for diagnosing coronary artery disease in stable patients or for risk stratification after an MI. It is not an appropriate initial investigation for acute chest pain with ST elevations.
• 24-hour Holter monitoring: This is used to detect heart rhythm abnormalities (arrhythmias) over an extended period. It is not the primary diagnostic tool for acute MI.

Conclusion

Given the clinical presentation and ECG findings strongly suggesting acute myocardial infarction, the most critical next step is to confirm heart muscle damage. Therefore, measuring cardiac marker troponin T/I is the next logical and essential investigation.